FdaApplication
NDA 021366
Identifiers
- fda_app_no: NDA021366
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA UK LTD |
| application_type | NDA |
| approval_date | 2003-08-12 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CRESTOR | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET;ORAL |
| CRESTOR | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET;ORAL |
| CRESTOR | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET;ORAL |
| CRESTOR | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET;ORAL |
4 products